Green Synthesis of Biodegradable Polymers in Pharmaceutical Manufacturing Plants

Thesis Abstract

The escalating environmental concerns associated with conventional polymer synthesis in pharmaceutical manufacturing necessitate the development of sustainable and environmentally friendly alternatives, particularly biodegradable polymers produced through green synthesis methods. This study aims to investigate the feasibility, efficiency, and environmental impact of green synthesis procedures for biodegradable polymers within pharmaceutical manufacturing plants, focusing on optimizing reaction parameters, evaluating the biodegradability, and assessing the process sustainability. The specific objectives include (1) to analyze the key factors influencing the green synthesis of biodegradable polymers such as polylactic acid and polyhydroxyalkanoates; (2) to develop and optimize green synthesis protocols using biocatalysis and renewable raw materials; (3) to characterize the physical, chemical, and biodegradable properties of the synthesized polymers; (4) to conduct a comparative environmental impact assessment against traditional synthesis methods; and (5) to evaluate the integration potential of these methods into existing pharmaceutical manufacturing processes. The research employs a mixed-methods design grounded in quantitative experimental techniques complemented by qualitative process analysis. A population sample of 15 pharmaceutical manufacturing plants within the region, selected through purposive sampling based on their production capacity and willingness to adopt sustainable processes, provides data for case studies. Data collection instruments include laboratory experimental setups for polymer synthesis, Fourier-transform infrared spectroscopy (FTIR), nuclear magnetic resonance (NMR) spectroscopy, and gel permeation chromatography (GPC) for polymer characterization, alongside environmental impact assessment tools such as life cycle assessment (LCA) software. Process parameters and outcomes from laboratory synthesis are analyzed using design of experiments (DOE) with response surface methodology (RSM) to optimize reaction conditions. Statistical data from the environmental impact assessments are subjected to ANOVA to determine significant differences between green and conventional synthesis routes, while thematic analysis is employed on qualitative data from interviews with process engineers to identify barriers and facilitators for implementation. Expected findings indicate that the optimized green synthesis protocols can produce biodegradable polymers with comparable or superior molecular weight distribution, mechanical strength, and biodegradability to traditionally synthesized counterparts but with significantly reduced energy consumption, greenhouse gas emissions, and waste generation. The findings are anticipated to reveal critical process parameters—such as catalyst type, temperature, pH, and raw material purity—that influence yield and polymer quality. A comprehensive environmental impact assessment is projected to demonstrate the ecological benefits of adopting green synthesis approaches, emphasizing reductions in carbon footprint and chemical waste. Moreover, the study will identify practical barriers to implementation, including technical, economic, and infrastructural challenges, providing insights into policy and process modifications required for large-scale industrial adoption. This research makes a significant contribution to the body of knowledge by providing a validated framework for green synthesis of biodegradable polymers tailored for pharmaceutical applications, integrating process optimization with sustainability metrics. Its novel approach of combining laboratory-based synthesis protocols with environmental impact assessments offers a holistic perspective necessary for industry stakeholders committed to environmental responsibility. The main conclusion underscores that green synthesis is a viable, sustainable alternative capable of enhancing the environmental profile of pharmaceutical manufacturing while maintaining product efficacy. It recommends the development of standardized protocols, incentives for green adoption, and further pilot studies to facilitate scaling. Additionally, future research should explore the integration of nanotechnology and bio-based catalysts to further improve process efficiency and product functionality. This study ultimately advocates for the strategic incorporation of green synthesis techniques within pharmaceutical industries to promote sustainable manufacturing practices aligned with global environmental objectives.